Analyst Ratings February 23, 2026

KeyBanc Raises Macerich Rating Citing Early Success of 'Path Forward' Plan

Analyst lifts stock to Overweight and sets $25 target as execution and deleveraging improve outlook

By Maya Rios MAC
KeyBanc Raises Macerich Rating Citing Early Success of 'Path Forward' Plan
MAC

KeyBanc upgraded The Macerich Company (NYSE: MAC) to Overweight from Sector Weight and established a $25.00 price target, pointing to execution on the company's multi-year Path Forward Plan that is running ahead of schedule. The firm highlighted a $107 million small-shop opening pipeline with base rents commencing through 2028, accelerated asset sales, and further deleveraging as drivers of a more favorable outlook. Macerich shares traded at $20.30, trading close to a 52-week high of $20.65 and rising 9.6% over the past week.

Key Points

  • KeyBanc upgraded Macerich to Overweight and set a $25.00 price target based on execution of the Path Forward Plan.
  • The Path Forward Plan includes a $107 million small-shop opening pipeline with annual base rent scheduled to commence through 2028, supporting anticipated cash flow improvements.
  • Accelerated dispositions and deleveraging, plus expected NOI growth and an FFO/AFFO inflection in 2026, are cited as drivers for potential multiple expansion.

KeyBanc has moved The Macerich Company (NYSE: MAC) to an Overweight rating from Sector Weight and placed a $25.00 price target on the shares. The analyst action follows what the firm described as stronger-than-expected progress executing the company’s multi-year Path Forward Plan.

Market reaction was positive: Macerich stock was trading at $20.30, close to its 52-week high of $20.65, and recorded a 9.6% gain over the past week.


What KeyBanc cited

  • KeyBanc said the Path Forward Plan is tracking ahead of expectations, a central reason for the rating change.
  • The plan incorporates a $107 million small-shop new opening pipeline, with annual base rent scheduled to commence through 2028.
  • Accelerated disposition activity and additional deleveraging were highlighted as factors that underpin a more constructive outlook for the mall operator.

The firm anticipates that improving net operating income (NOI) growth and an inflection in funds from operations (FFO) and adjusted funds from operations (AFFO) in 2026 will help drive multiple expansion for the shares.

KeyBanc also pointed to several internal and potential external supports for value creation, including EBITDA growth, loan givebacks, and the prospect of accretive acquisitions. Taken together, the analyst expects these items to contribute to above-average net asset value growth as the Path Forward Plan progresses.


Company profile

Macerich operates regional shopping centers across the United States. The company’s operational and financial initiatives under the Path Forward Plan are central to KeyBanc’s reassessment of the firm’s near- to medium-term prospects.


Key points

  • Analyst upgrade to Overweight and a $25.00 price target reflects accelerated execution on Macerich’s strategic plan.
  • A $107 million small-shop opening pipeline with base rents scheduled through 2028 is a material element of projected cash flow improvement.
  • Disposition activity and deleveraging are expected to support NOI, FFO/AFFO inflection in 2026, and potential multiple expansion.

Risks and uncertainties

  • Execution risk - continued progress on the Path Forward Plan is necessary to realize the cited benefits.
  • Timing risk - the expected inflection in FFO and AFFO is anticipated in 2026, and outcomes depend on reaching that milestone.
  • Transaction risk - the constructive outlook relies in part on accelerated dispositions and potential accretive acquisitions; those activities carry execution and market risks.

The information above reflects KeyBanc’s stated views and Macerich’s disclosed operational elements as cited by the firm. Readers should note that the assessment and the projected timing of financial inflection points are based on the components identified by the analyst.

Risks

  • Execution risk: Realizing benefits depends on the continued implementation of the Path Forward Plan.
  • Timing risk: The expected improvement in FFO and AFFO is projected for 2026 and may be subject to timing variability.
  • Transaction risk: Outcomes depend on successful accelerated asset dispositions and any accretive acquisitions, which carry market and execution uncertainties.

More from Analyst Ratings

RBC Capital Lowers Imperial Oil Rating, Citing Valuation Disconnect Feb 23, 2026 RBC Capital Lifts Banco Santander to Outperform, Cites Cost Cuts and Strategic Deals Feb 23, 2026 RBC Capital Lowers Rating on Athabasca Oil, Raises Long-Run Price Target Feb 23, 2026 Jefferies Lowers Deere Rating, Cites Stretched Valuation Despite Strong Quarterly Results Feb 23, 2026 Jefferies Starts Coverage on York Space Systems With Buy Rating, $37.00 Target Feb 23, 2026